<DOC>
	<DOCNO>NCT00006234</DOCNO>
	<brief_summary>RATIONALE : Radioactive drug , holmium Ho 166 DOTMP , may carry radiation directly cancer cell harm normal cell . Peripheral stem cell transplantation may able replace stem cell destroy radioactive drug . PURPOSE : This Phase I/II trial study effectiveness holmium Ho 166 DOTMP follow peripheral stem cell transplantation treat patient metastatic Ewing 's sarcoma rhabdomyosarcoma spread bone .</brief_summary>
	<brief_title>Holmium Ho 166 DOTMP Followed Peripheral Stem Cell Transplantation Treating Patients With Metastatic Ewing 's Sarcoma Rhabdomyosarcoma That Has Spread Bone</brief_title>
	<detailed_description>OBJECTIVES : - Determine dosimetry holmium Ho 166 DOTMP patient metastatic Ewing 's sarcoma family tumor rhabdomyosarcoma bone metastasis . - Provide treatment holmium Ho 166 DOTMP patient . - Determine toxicity pharmacokinetics drug patient . - Determine change tumor cell content peripheral blood bone marrow treatment drug patient . OUTLINE : Patients receive trace dose holmium Ho 166 DOTMP IV 10 minute day -7 assign dose 10 minute day 0 . Autologous peripheral blood stem cell infused day 7-10 . Patients follow least weekly 4 week monthly 1 year disease progression . PROJECTED ACCRUAL : A total 4 patient accrue study .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Sarcoma , Ewing</mesh_term>
	<mesh_term>Rhabdomyosarcoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm Ewing 's sarcoma family tumor rhabdomyosarcoma bone metastasis Refractory conventional therapy OR Responsive conventional therapy osseous metastasis diagnosis extensive enough preclude concurrent radiotherapy site Soft tissue , pulmonary , and/or bone marrow metastases addition cortical bone allow Extraosseous site disease allow amenable surgical resection external beam radiotherapy No patient 10 year old embryonal rhabdomyosarcoma Adequate peripheral blood stem cell store At least 2,500,000 CD34+ cells/kg No impend bone fracture spinal cord compression PATIENT CHARACTERISTICS : Age : 12 Performance status : 02 Life expectancy : At least 2 month Hematopoietic : Absolute neutrophil count least 1,000/mm^3 Platelet count least 75,000/mm^3 ( transfusion independent ) Hemoglobin least 10.0 g/dL ( RBC transfusion allow ) Hepatic : Bilirubin great 1.5 time normal SGOT great 2.5 time normal Renal : Radioisotope glomerular filtration rate , iothalamate clearance , creatinine clearance least 60 mL/min Other : No uncontrolled infection Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Recovered prior immunotherapy At least 3 month since prior bone marrow peripheral blood stem cell transplantation ( 6 month total body irradiation condition ) recover At least 1 week since prior cytokine No immunomodulators least 4 week study No concurrent cytokines Chemotherapy : At least 3 week since prior chemotherapy ( 6 week nitrosoureas ) recover No 3 prior systemic chemotherapy regimens No systemic chemotherapy least 4 week study Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics See Biologic therapy Recovered prior radiotherapy No prior maximum tolerable radiotherapy ( great 30 Gy ) spinal cord No prior therapeutic dos boneseeking radiopharmaceutical ( e.g. , samarium Sa 153 lexidronam pentasodium EDTMP ) No radiotherapy least 4 week study Local radiotherapy tumor site allow provide least 1 evaluable lesion untreated Surgery : See Disease Characteristics No surgical resection bone metastases evaluable PET 1 month study Other : At least 4 week since prior bisphosphonates</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>recurrent childhood rhabdomyosarcoma</keyword>
	<keyword>recurrent adult soft tissue sarcoma</keyword>
	<keyword>adult rhabdomyosarcoma</keyword>
	<keyword>bone metastasis</keyword>
	<keyword>previously treat childhood rhabdomyosarcoma</keyword>
	<keyword>metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>stage IV adult soft tissue sarcoma</keyword>
</DOC>